Veritas In Silico issued Series 6 to Series 9 stock acquisition rights and announced the number allotted in each series, the payment date and the exercise period. Details were provided on the number of potential shares and the issue price and exercise price for each series.
Veritas In Silico disclosed the issuance of Series 6 to Series 9 stock acquisition rights. Series 6 and Series 7 comprise 2000 units each, while Series 8 and Series 9 comprise 1000 units each, for a total issue of 6000 units.
The rights were allocated to a total of 3 parties. The payment date is 29 October, and the exercise period runs from 30 October to 29 October 2029. The total number of potential shares is 200,000 each for Series 6 and Series 7, and 100,000 each for Series 8 and Series 9.
The issue price and exercise price differ by series: ¥52 and ¥600, respectively, for Series 6; ¥39 and ¥800 for Series 7; ¥35 and ¥1,000 for Series 8; and ¥34 and ¥1,250 for Series 9.